Best Topics

Gretchen Vogelscience: Latest News

All news where Gretchen Vogelscience is mentioned

27.03.2021 / 18:41

A rare clotting disorder may cloud the world's hopes for AstraZeneca's COVID-19 vaccine

Kai Kupferschmidt, Gretchen VogelScience’s COVID-19 reporting is supported by the Heising-Simons Foundation.In the tumultuous rollout of AstraZeneca's COVID-19 vaccine, all eyes were on the United States this week, where the company had a highly public communication breakdown over the vaccine's efficacy with an expert panel overseeing a large study in the Americas.

Kai Kupferschmidt Usa Germany covid-19 vaccine patient

Could a rare clotting disorder dash the world's hopes for AstraZeneca's COVID-19 vaccine?

Kai Kupferschmidt Usa Germany covid-19 vaccine patient

AstraZeneca reports powerful COVID-19 protection in new vaccine trial

Kai Kupferschmidt, Gretchen VogelScience’s COVID-19 reporting is supported by the Heising-Simons Foundation.The long-awaited results from a new trial of AstraZeneca’s COVID-19 vaccine hold some good news for the company, which in recent weeks has had to address eroding confidence in its shots amid news of possible rare, serious side effects. In a press release published on Monday morning, the company announced that the trial, which included more than 32,000 participants in Chile, Peru, and the United States, had shown the vaccine to have 79% efficacy at preventing symptomatic COVID-19.“I’m thrilled,” says Ashish Jha, dean of Brown University’s School of Public Health.

Kai Kupferschmidt Ashish Jha Usa Chile Peru covid-19 vaccine

European countries resume use of AstraZeneca's COVID-19 vaccine, hoping pause has not dented confidence

Kai Kupferschmidt, Gretchen VogelScience’s COVID-19 reporting is supported by the Heising-Simons Foundation.A dozen European countries today said they will resume vaccinations with the AstraZeneca vaccine against COVID-19 after the European Medicines Agency (EMA) said its initial investigation of possible side effects has concluded the vaccine is “safe and effective.” Their decisions came as a relief to many public health experts, who worried about long delays in the COVID-19 vaccination programs at a time when cases are increasing in much of Europe.At a press conference this afternoon, EMA officials said their inquiry could not rule out a connection between the vaccine and certain unusual clotting and bleeding disorders, but they concluded

Kai Kupferschmidt covid-19 vaccine

COVID-19

United States	Cases: 46 252 513 Deaths: 750 423 Recovered: 0
India	Cases: 34 321 025 Deaths: 459 652 Recovered: 0
Brazil	Cases: 21 835 785 Deaths: 608 235 Recovered: 0
United Kingdom	Cases: 9 215 683 Deaths: 141 607 Recovered: 0
Russia	Cases: 8 494 589 Deaths: 237 619 Recovered: 0

Detail statistic

About Us

Covid-19.rehab - the latest news concerning the spread of the SARS-CoV-2 coronavirus (formerly 2019-nCoV), as well as the infectious disease that it causes COVID-19, in separate countries and in the world as a whole. Current news on the topic of coronavirus SARS-CoV-2. Quarantine, pandemic 2020, epidemic: what is it, when will it come to end, precautions and how to protect yourself from this disease. The most honest news, no fakes! To keep up with the latest news, stay tuned for updates on the site! Every day we will collect news and statistics on coronavirus from around the world for you to be aware of this topic.

Owner: SNOWLAND s.r.o.
Registration certificate 06691200
Address:
Snowland s.r.o.
16200, Na okraji 381/41, Veleslavín, 162 00 Praha 6
Czech Republic